THE WHAT? Boots Chief Executive Officer Ornella Barra is stepping down from her role after leading the British health and beauty retailer for almost ten years.
THE DETAILS Barra will transition to Chair of the Board, replacing Stefano Pessina, and will take oversight of the company’s ESG agenda. Pessina, a major shareholder, will remain on the board following the separation of Boots from Walgreens Boots Alliance, which was acquired by Sycamore Partners in a US$10 billion deal last year.
Since the transaction, Boots has been operating as a private, UK-headquartered business. The Boots Group now encompasses pharmacy-led health and beauty operations globally, as well as a pharmaceutical wholesale business in Germany. Anthony Hemmerdinger, currently Senior Vice President and Managing Director for the UK, Ireland and Opticians, will assume expanded responsibilities, including oversight of No7 Beauty and group-level functions.
THE WHY? The leadership change marks a new chapter for Boots as it continues to operate independently following its separation from Walgreens Boots Alliance. Barra’s move to chair signals continuity in governance and ESG priorities, while the expanded remit for Hemmerdinger reflects a focus on streamlining leadership across health and beauty operations.
Source: Bloomberg
